Pharmaceutical Composition Comprising Nanog SHRNA, and Method of Using Nanog SHRNA to Treat Cancer
Technology
E-294-2010
Patent ID
E-294-2010-1-US-01
Country
US
Application Type
CIP
Patent Status
Issued
Patent Number
9512429
Publication Number
US20160032290A1
Application Number
14/886,970
IC
NCI
Date Filed
Date Issued